Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Genes & Cancer is not an online course or training platform in the traditional sense, but a peer-reviewed, open-access academic journal focused on cancer research. Its topics cover oncogenes, tumor suppressors and apoptosis-related genes, signal transduction, developmental biology, genomics, drug development, systems biology, and related areas. It primarily serves scientific publishing and academic dissemination.
From an education/course perspective, it is better understood as an advanced research-learning and paper-publication resource. The journal was founded by Dr. E. Premkumar Reddy, who is described on the site as having founded and long served as editor of Oncogene. The editorial board of Genes & Cancer consists of scientists in oncogenes, signal transduction, cancer therapy, and biomedical research. The journal uses single-blind peer review, with a process that includes editorial screening, external expert review, author revision, and a final editorial decision. On average, there are about three reviewers, with at least two, and up to three rounds of revision are allowed. Articles are published under the CC BY 4.0 open license and are indexed in PMC and PubMed.
The site mentions a “Publication Fees” section, indicating that open-access publication fees may apply. However, the captured content does not disclose specific amounts, waiver policies, or payment methods, so the cost level cannot be assessed.
The main advantage is its focused research scope, making it suitable for researchers in cancer genetics and tumor biology. Its publication ethics policies are comprehensive, following standards such as COPE and ICMJE, and clearly specifying requirements for clinical trials, informed consent, animal experiments, AI tool use, plagiarism checks, and image forensics. Altmetric reports also help authors track the dissemination impact of their papers.
The drawbacks are also clear: it does not provide course syllabi, video lessons, assignments, certificates, or learning paths. The content has a high barrier to entry and is difficult for general learners to use directly. Fee information is incomplete, so authors preparing to submit need to investigate further.
It is suitable for researchers, PhD students, principal investigators, and medical research authors working in cancer research, molecular biology, genetics, clinical research, drug development, and systems biology. If the goal is to study a basic oncology course, it is not the best choice.
The content does not provide information about access from mainland China, so it is unclear whether the site can be reached directly. Access status is assessed as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on genesandcancer.com official site.
genesandcancer.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach genesandcancer.com directly.